A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine.

Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.

Findings indicate a serine/glycine-free diet can reduce colorectal cancer growth and enhance immune response, offering ...

Natural killer (NK) cells play an important role in the innate immune response to cancer and viral infections, and their ...

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

(“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of ... by boosting the quality and quantity of cancer fighting immune cells, ...

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, has reported preclinical data showing strong ...

New research shows white blood cells activated by COVID-19 may have cancer-fighting abilities, offering hope for future ...

Thailand's foremost hematopoietic (HSC), mesenchymal stem cell (MSC) bank and leader in regenerative healthcare, has received ...

Researchers from Naya Biosciences Inc. and collaborators presented preclinical data on NY-303, a natural killer (NK) cell engager bispecific antibody targeting both GPC3 and NKp46. NKp46 is a cell ...

After treatment with white button mushroom extract in mice and patients with prostate cancer, scientists discovered a decline ...